Lung Therapeutics pursues innovative treatments for underserved, life-threatening lung conditions. Their therapies for Idiopathic Pulmonary Fibrosis and Loculated Pleural Effusion bring hope to patients whose only treatment options may be invasive surgery or costly and ineffective drugs. Lung Therapeutics aims to create better pharmaceutical treatment options for IPF, LPE, and other underserved lung conditions.

Learn more at:

Connect with Lung Therapeutics